香雪製藥(300147.SZ):擬出資1億元對香雪智慧中醫增資
格隆匯12月24日丨香雪製藥(300147.SZ)公佈,為優化公司全資子公司廣東香雪智慧中醫藥產業有限公司(“香雪智慧中醫”)的資產負債結構、進一步增強資本實力,促進業務的快速發展,提升自身融資能力,公司將以香雪智慧中醫的註冊資本為參考依據,以現金出資1億元對其進行增資,增資完成後,香雪智慧中醫的註冊資本由1.6億元增至2.6億元。
本次增資事項,有利於增強子公司的資金實力並優化其資本結構,補充經營發展中的營運資金需求,提升自身融資能力,提升其業務承接能力,加強其市場競爭力,符合公司戰略規劃及長遠利益。本次增資不會導致公司合併報表範圍的變動,不會對公司財務及經營狀況產生不利影響,不存在損害公司及全體股東利益的情況。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.